How Much Did StemRad Raise?
Funding & Key Investors

StemRad has successfully secured a significant capital injection, bringing its total funding to $6M. This latest infusion, characterized by a $6M strategic investment, underscores the company's pivotal role in the high-stakes sector of radiation protection. By securing this financing, StemRad is well-positioned to accelerate its mission of providing critical shielding solutions to high-risk professionals across military, medical, and aerospace sectors.

What is StemRad?

StemRad
ManufacturingMedical Devices & Equipment

StemRad operates at the intersection of advanced materials science and life-saving personal protective equipment. The company is best known for its proprietary Radiation Shield, a specialized technology designed to protect vital organs from ionizing radiation without compromising the mobility of the wearer. By targeting the bone marrow and other radiation-sensitive areas, StemRad provides a unique value proposition that differentiates its offerings from traditional, bulky lead-based shielding. Their market position is bolstered by a diverse client base, including first responders, military personnel, and astronauts, all of whom require high-performance gear that facilitates operational efficiency in hazardous environments. As the global demand for radiation safety solutions grows, StemRad remains a leader in mitigating both acute radiation syndrome and long-term cancer risks associated with occupational exposure.

How much funding has StemRad raised?

StemRad has raised a total of $6M across 1 funding round:

2017

Series C

$6M

Series C (2017): $6M, investors not publicly disclosed

Key Investors in StemRad

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for StemRad?

With the recent influx of capital, StemRad is poised to transition into a new phase of enterprise-level scaling. The strategic roadmap likely involves expanding manufacturing capabilities to meet the increasing requirements of government defense contracts and international medical agencies. Furthermore, the company is expected to invest heavily in research and development to refine its shielding materials, potentially exploring new applications in deep-space exploration and nuclear disaster response. By leveraging this financial backing, StemRad aims to solidify its market dominance, ensuring that its life-saving technology becomes the standard for personnel operating in environments where radiation exposure is an unavoidable reality. The focus will remain on balancing high-level protection with ergonomic design, ensuring that the next generation of products continues to set the benchmark for safety and performance in the field.

See full StemRad company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Chemicals & Related ProductsManufacturingEducationHealth & Nutrition ProductsTrainingHealthcare ServicesMedical Laboratories & Imaging Centers
ManufacturingMedical Devices & EquipmentBusiness ServicesResearch & Development
Building MaterialsManufacturingArchitecture, Engineering & DesignConstruction ManagementConstructionIndustrial Machinery & Equipment
Food & BeverageManufacturingRetailGrocery Retail

Frequently Asked Questions Regarding StemRad Financial Insights

What are the most recent funding rounds that StemRad has completed, and what were the funding rounds?
StemRad has recently completed 1 funding rounds: Series C on Dec 2, 2017.
What is the total amount of funding StemRad has raised to date?
StemRad has raised a total of $6M in funding to date.
How many funding rounds has StemRad completed?
StemRad has completed 1 funding rounds.
How much funding did StemRad raise in its most recent funding round?
StemRad raised $6M in its most recent funding round.
Which was the largest funding round in StemRad's history?
The largest funding round in StemRad's history was $6M.
See more information about StemRad